Diabetic patients are at higher risk from novel coronavirus disease 2019 (COVID-19) that spreads through Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There are around 20% to 50% of COVID-19 cases who had diabetes across the different regions of the world. This article discusses recommendations and associated risks for diabetic patients to balance glycemic profiles during the COVID-19 outbreak. It also discusses the case study of various countries with impact of COVID-19 for diabetic patients. It presents emerging smart healthcare that can potentially safeguard against COVID-19. 1) The fluctuation of blood sugar affects the immunity of a person which exposes him
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.